Product Images Eptifibatide

Eptifibatide injection is a medication provided in a 10 mL vial that contains 2 mg eptifivatice and 5.25 mg citric acid in water for injection. The pH of the solution is 5.35 and is adjusted with sodium hydroxide. The usual dose for this medication is indicated in the package insert. It needs to be stored refrigerated at 2°-6°C (36°-46°F) and should be transferred to 25°C (77°F, USP Controlled Room Temperature) for up to 2 months. It also needs protection from light until administration. The medication is manufactured by Inas Pharmaceuticals Limited in Ahmedabad, India and is licensed under Mig. Lic. No. G/1026.*

Eptifibatide is a medication administered through injection for intravenous use only. A single 100mL vial contains 200mg of eptifibatide with 2mg/mL concentration. Each mL also contains 5.25mg citric acid in water with pH adjusted using sodium hydroxide to 5.35. It is advised to store refrigerated at 2°C to 8°C and may be transferred to USP controlled temperature 25°C for 2 months at most. Protect from light until administration. Manufacturing for Accord Healthcare is at Durham, North Carolina, whereas Intas Pharmaceuticals Limited in India is responsible for production. More details about dosages are included in the package insert.*

Eptifibatide is a medication administered intravenously and available in a 100 mL single-use vial, with each mL containing 0.75 mg of eptifibatide and 5.25 mg of citric acid in water for injection. The pH level of the solution is adjusted using sodium hydroxide to maintain pH 5.35. The usual dose is detailed in the package insert, and the medication should be stored refrigerated at 2°-8°C (36°-46°F) and protected from light until administration. The solution may be stored at 25°C (77°F; USP Controlled Room Temperature) for two months. This particular medication was manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India and is distributed under the brand name Eptifibatide injection by Accord Healthcare Inc. of Durham, North Carolina in the United States.*

This text is a description of a medication called Eptifibatide. It comes in a 20mg/10mL vial for weight-adjusted bolus dosing to be used intravenously. The medication is manufactured by Intas Pharmaceuticals Limited in India and distributed by Accord Healthcars Inc. in Durham, NC. The medication is only for a single-use and must be stored at room temperature. The text includes warnings and instructions on how to properly handle and dispose of the medication.*

This is a description of a 200 mg/100mL vial of Eptifibatide, an injection used for weight-adjusted infusion. It includes instructions for use and storage guidelines, as well as manufacturing information for the drug. A section advises keeping an area blank and varnish-free for overcoding Lot and EXP, with a 2D Matrix included.*

This text contains information about two different products. The first section appears to be instructions for labeling and coding a product. The second section is for a medication called Eptifibatide, which is meant for intravenous use only. The medication comes in a single-use vial and each mL contains 0.75 mg eptifibatide and 5.25 mg citric acid in water for injection. The usual dose is not provided and must be referred to the accompanying package insert. The medication needs to be refrigerated at 2°-8°C but can be transferred to 25°C for up to 2 months before being used. If not used within this timeframe, it must be discarded. Protect it from light until administration. The text also includes manufacturer and product details, but it lacks clarity and consistency.*